Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02533726 · ClinicalTrials.gov registry record · NA
Optimal Patient Turning for Reducing Hospital Acquired Pressure Ulcers
A NA study, sponsored by Stanford University.
- Completed
- Registry status
- NA
- Development phase
- 1,312
- Enrollment target
NCT02533726: Completed NA study, sponsored by Stanford University.
NCT02533726 is a NA study that has completed, run by Stanford University. The registered enrollment target is 1,312 participants, roughly in line with the 1,404-participant average among 58,714 other NA trials with a reported enrollment target. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02533726, a NA study, has completed, sponsored by Stanford University.
- COMPLETED
- Registry status
- NA
- Development phase
- 1,312 participants
- Enrollment target
Study Summary
The purpose of this study is to test whether optimal patient turning, strictly every 2 hours with at least 15 minutes of tissue decompression, reduces the occurrence of hospital acquired pressure ulcers.
Primary Outcome
NPUAP criteria include 4 stages and 2 unstaged criteria. The count of patients with pressure ulcer according to any of the criteria are reported. * Stage 1: Non-blanchable erythema of intact skin * Stage 2: Partial-thickness skin loss with exposed dermis * Stage 3: Full-thickness skin loss * Stage 4: Full-thickness skin and tissue loss * Unstageable: Obscured full-thickness skin and tissue loss * Suspected deep tissue injury: Persistent non-blanchable deep red, maroon or purple discoloration
Interventions
- OTHER Optimal Turning
- OTHER Standard Care Practices
- OTHER Patient Sensor
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,312 participants |
| Start Date | 2015-08 |
| Est. Completion | 2016-02 |
| Phase | NA |
What the finished NCT02533726 record still lists
NCT02533726 is an interventional study that assigns participants to a tested intervention. Its 1,312 participants enrollment target places it among the larger protocols in the corpus, roughly in line with the 1,404-participant average among 58,714 other NA trials with a reported enrollment target.
The record links to 0 conditions, and to 3 interventions - of which Optimal Turning is the first listed.
NCT02533726 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02533726 about?
NCT02533726 is a clinical study titled "Optimal Patient Turning for Reducing Hospital Acquired Pressure Ulcers". The purpose of this study is to test whether optimal patient turning, strictly every 2 hours with at least 15 minutes of tissue decompression, reduces the occurrence of hospital acquired pressure ulcers.
What is the current status of trial NCT02533726?
This trial is currently completed. It is a NA study. The enrollment target is 1,312 participants. The study started on 2015-08. Estimated completion is 2016-02.
What interventions are being tested in trial NCT02533726?
The interventions under investigation include: Optimal Turning (OTHER), Standard Care Practices (OTHER), Patient Sensor (OTHER).
Who is sponsoring clinical trial NCT02533726?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02533726's enrollment target sits among peer trials
1,312 76th of 2000 higher than 1,925 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06556433 · 1,312 participants · NA
Family-Based Financial Incentives Intervention for Smoking Cessation
- NCT05176483 · 1,314 participants · Phase 1
Study of Zanzalintinib in Combination With Immuno-Oncology Agents in Participants With Solid Tumors
- NCT06136650 · 1,314 participants · Phase 3
A Study of Opevesostat (MK-5684) Versus Alternative Next-generation Hormonal Agent (NHA) in Metastatic Castration-resistant Prostate Cancer (mCRPC) Post One NHA (MK-5684-004)
- NCT06136624 · 1,310 participants · Phase 3
Study of Opevesostat (MK-5684) Versus Alternative NHA in mCRPC (MK-5684-003)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia